Literature DB >> 30335901

MicroRNA-212 suppresses nonsmall lung cancer invasion and migration by regulating ubiquitin-specific protease-9.

Wei Chen1, Yuye Huang2, Shufen Zhang1, Xiaoxiao Zheng1, Shangzhi Xie1, Jiayan Mao1, Ying Cai1, Xuemei Lu1, Liqiang Hu1, Jian Shen1, Ying Dong3, Kequn Chai1.   

Abstract

MicroRNAs (miRNAs) play crucial roles in various biological processes, including migration, proliferation, differentiation, cell cycling, and apoptosis. Epithelial-mesenchymal transition (EMT) has been shown to be related to the capability of migration and invasion in many tumor cells. In this study, we used wound-healing assay and transwell invasion to analysis the capability of migration and invasion in non-small-cell lung carcinoma (NSCLC), respectively. The expression of ubiquitin-specific protease-9-X-linked (USP9X) and miR-212 messenger RNA (mRNA) was determined by quantitative real-time polymerase chain reaction and Western blot analysis was used to determine the E-cadherin and vimentin expression. Our results showed that miR-212 mimic inhibited cell migration and invasion, while miR-212 inhibitor increased cell migration and invasion. There was no significant difference between WP1130 and miR-212 mimic combined with WP1130 groups. Moreover, WP1130 inhibited the capability of the migration and invasion of NSCLC cells. Western blot analysis displayed that miR-212 mimic upregulated E-cadherin expression and downregulated vimentin expression, while miR-212 inhibitor downregulated E-cadherin and upregulated vimentin expression. These data showed that miR-212 regulated NSCLC cell invasion and migration by regulating USP9X expression. Taken together, these findings indicated that miR-212 regulated NSCLC cells migration and invasion through targeting USP9X involved in EMT.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  epithelial-mesenchymal transition; invasion and migration; microRNA; non-small-cell lung carcinoma; therapeutic; ubiquitin-specific protease-9-X-linked

Mesh:

Substances:

Year:  2018        PMID: 30335901     DOI: 10.1002/jcb.27939

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

Review 1.  A perspective to weaponize microRNAs against lung cancer.

Authors:  Dhanashree Murugan; Loganathan Rangasamy
Journal:  Noncoding RNA Res       Date:  2022-09-29

2.  Upregulation of microRNA 344a-3p is involved in curcumin induced apoptosis in RT4 schwannoma cells.

Authors:  Eun Jung Sohn; Kyoung-Mi Bak; Yun-Kyeong Nam; Hwan Tae Park
Journal:  Cancer Cell Int       Date:  2018-12-04       Impact factor: 5.722

3.  microRNA-605 inhibits the oncogenicity of non-small-cell lung cancer by directly targeting Forkhead Box P1.

Authors:  Wei Zhou; Ruichao Li
Journal:  Onco Targets Ther       Date:  2019-05-17       Impact factor: 4.147

4.  MicroRNA-374b mediates the initiation of non-small cell lung cancer by regulating ITGB1 and p53 expressions.

Authors:  Meng Zhao; Chuntang Tong; Zerui Hao; Ruixing Zhao; Liming Wang
Journal:  Thorac Cancer       Date:  2020-05-04       Impact factor: 3.500

Review 5.  The functions and targets of miR-212 as a potential biomarker of cancer diagnosis and therapy.

Authors:  Wenjun Chen; Jing Song; Hongjun Bian; Xia Yang; Xiaoyu Xie; Qiang Zhu; Chengyong Qin; Jianni Qi
Journal:  J Cell Mol Med       Date:  2020-01-13       Impact factor: 5.310

6.  Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis.

Authors:  Biqing Wang; Xuening Tang; Liu Yao; Yuxin Wang; Zhipeng Chen; Mengqi Li; Naishi Wu; Dawei Wu; Xiangchen Dai; Hongfeng Jiang; Ding Ai
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

7.  miR-512-5p suppresses the progression of non-small cell lung cancer by targeting β-catenin.

Authors:  Zhexin Wang; Xiaolei Zhu; Tuo Zhang; Feng Yao
Journal:  Oncol Lett       Date:  2019-11-14       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.